Stockreport

Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative thera [Read more]